Dyne Therapeutics, Inc. (DYN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Joshua T. Brumm
Employees:
100
830 WINTER STREET, WALTHAM, MA 02451
(781) 786-8230

Dyne Therapeutics, Inc., a muscle disease company, focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 650.478 Million Shares Outstanding61.02 Million Avg 30-day Volume 751.814 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.8
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value657.802 Million
Current Ratio0 EPS Growth0 Quick Ratio0
1 Yr BETA 1.5866 52-week High/Low 15.6 / 6.4 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 6.593 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score0.0

Are you looking for this stock instead?

View SEC Filings from DYN instead.

View recent insider trading info

Funds Holding DYN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DYN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-10-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-03-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-12:
    Item 8.01: Other Events
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-05:
    Item 8.01: Other Events
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    9.9 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BRUMM JOSHUA T SEE REMARKS

    • Officer
    • Director
    592,556 2023-11-15 6

    HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

    • Officer
    189,498 2023-11-15 7

    SCALZO RICHARD WILLIAM SEE REMARKS

    • Officer
    130,537 2023-11-15 6

    BESKROVNAYA OXANA CHIEF SCIENTIFIC OFFICER

    • Officer
    178,052 2023-11-15 6

    MCNEILL JONATHAN CHIEF BUSINESS OFFICER

    • Officer
    156,763 2023-11-15 8

    FARWELL WILDON CHIEF MEDICAL OFFICER

    • Officer
    171,762 2023-11-15 5

    HURWITZ EDWARD

    • Director
    0 2023-05-24 1

    LUBNER DAVID CHARLES

    • Director
    0 2023-05-24 1

    RHODES JASON P

    • Director
    0 2023-05-24 2

    STEHMAN-BREEN CATHERINE

    • Director
    0 2023-05-24 1

    KERSTEN DIRK

    • Director
    • 10% Owner
    0 2023-05-24 1

    INCERTI CARLO

    • Director
    0 2023-05-24 1

    ATLAS VENTURE OPPORTUNITY FUND II, L.P.

    ATLAS VENTURE FUND XI, L.P.

    ATLAS VENTURE ASSOCIATES XI, L.P.

    ATLAS VENTURE ASSOCIATES XI, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LP

    ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC

    • 10% Owner
    9,869,483 2022-12-12 1

    KLEIN LAWRENCE OTTO

    • Director
    7,222 2022-07-05 0

    ATLAS VENTURE FUND XI, L.P.

    • 10% Owner
    7,326,117 2021-07-13 1

    MPM BIOVENTURES 2018, L.P.

    MPM BIOVENTURES 2018 (B), L.P.

    MPM ASSET MANAGEMENT INVESTORS BV2018 LLC

    MPM BIOVENTURES 2018 GP LLC

    MPM BIOVENTURES 2018 LLC

    EVNIN LUKE

    FOLEY TODD

    GADICKE ANSBERT

    • 10% Owner
    4,951,303 2020-09-21 0

    RA CAPITAL MANAGEMENT, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    No longer subject to file 2020-09-21 0

    ATLAS VENTURE FUND XI, L.P.

    ATLAS VENTURE ASSOCIATES XI, L.P.

    ATLAS VENTURE ASSOCIATES XI, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    9,748,915 2020-09-21 1

    VV MANAGER II, LLC

    VIDA VENTURES II, LLC

    VIDA VENTURES II-A, LLC

    • 10% Owner
    No longer subject to file 2020-09-21 0

    LOGOS GLOBAL MANAGEMENT LP

    • 10% Owner
    No longer subject to file 2020-09-21 0

    FLEXON ROBERT C PRESIDENT AND CEO

    • Officer
    • Director
    720,506 2017-03-24 0

    KUERSTEINER RICHARD LEE

    • Director
    14,713 2016-03-16 0

    WOOD PATRICK III

    • Director
    45,023 2015-12-08 0

    THOMPSON DANIEL P. EVP

    • Officer
    19,583 2015-11-10 0

    ALONSO MARIO E EVP-STRATEGIC DEVELOPMENT

    • Officer
    38,409 2015-10-29 0

    STEIN JEFFREY SCOTT

    • Director
    15,489 2015-08-21 0

    DALEY MARTIN W. EXECUTIVE VICE PRESIDENT

    • Officer
    21,055 2015-08-21 0

    ACKERMANN HILARY E.

    • Director
    15,489 2015-08-20 0

    PETRONE SHEREE M. EXECUTIVE VICE PRESIDENT

    • Officer
    16,790 2015-08-20 0

    BURKE CAROLYN JEANNE EVP

    • Officer
    62,647 2015-08-18 0

    JONES HENRY D. EVP & CHIEF COMMERCIAL OFFICER

    • Officer
    64,005 2015-08-18 0

    COX JULIUS EVP - CAO

    • Officer
    18,348 2015-08-17 0

    FREELAND CLINT EXEC. VP AND CFO

    • Officer
    71,894 2015-08-13 0

    CALLAWAY CATHERINE B. EXEC VP AND GENERAL COUNSEL

    • Officer
    63,042 2015-08-13 0

    SULT JOHN R

    • Director
    25,039 2015-08-11 0

    BARBAS PAUL M

    • Director
    14,679 2015-02-27 0

    LITESPEED MANAGEMENT, L.L.C.

    ZIMMERMAN, JAMIE

    LITESPEED MASTER FUND, LTD.

    • 10% Owner
    57,014,582 2012-07-02 0

    ELWARD THOMAS W

    • Director
    8,070 2011-03-31 0

    ICAHN CARL C

    IPH GP LLC

    ICAHN CAPITAL LP

    ICAHN ENTERPRISES G.P. INC.

    ICAHN ENTERPRISES HOLDINGS L.P.

    BECKTON CORP

    • 10% Owner
    18,042,212 2011-03-01 0

    HAMMICK PATRICIA A

    • Director
    60,125 2010-12-31 0

    TRUBECK WILLIAM L

    • Director
    46,125 2010-12-31 0

    GRIJALVA VICTOR

    • Director
    42,681 2010-12-31 0

    BIEGLER DAVID W

    • Director
    45,125 2010-12-31 0

    SHEPPARD HOWARD B

    • Director
    39,751 2010-12-31 0

    ICAHN CARL C

    • 10% Owner
    12,000,000 2010-11-10 0

    WILLIAMSON BRUCE A CHAIRMAN & CEO

    • Officer
    • Director
    1,136,381 2008-08-11 0

    NICHOLS HOLLI EVP AND CFO

    • Officer
    121,080 2007-04-24 0

    FURBACHER STEPHEN A PRESIDENT AND COO

    • Officer
    249,550 2007-04-24 0

    BLODGETT J KEVIN GENERAL COUNSEL & EXEC VP

    • Officer
    6,000 2007-04-24 0

    LEDNICKY LYNN A EXECUTIVE VICE PRESIDENT

    • Officer
    5,600 2007-04-24 0

    STONE CAROLYN J SVP AND CONTROLLER

    • Officer
    15,102 2007-04-24 0

    HOCHBERG JASON EXEC VP

    • Officer
    49,366 2007-04-24 0

    CLARK THOMAS D JR

    • Director
    42,014 2007-04-16 0

    MAZANEC GEORGE L

    • Director
    32,464 2007-04-16 0

    OELKERS ROBERT C

    • Director
    49,779 2007-04-16 0

    CHEVRON CORP

    CHEVRON USA INC

    CHEVRON INVESTMENTS INC.

    CHEVRON U.S.A. HOLDINGS INC.

    TEXACO INC

    • 10% Owner
    96,891,014 2007-04-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BESKROVNAYA OXANA - Officer CHIEF SCIENTIFIC OFFICER

    2023-11-16 16:23:49 -0500 2023-11-15 A 36,495 a 36,495 direct

    BESKROVNAYA OXANA - Officer CHIEF SCIENTIFIC OFFICER

    2023-11-16 16:23:49 -0500 2023-11-15 A 93,718 a 178,052 direct -3.3575 0.0 1 -3.3575 2

    HIGH SUSANNA GATTI - Officer CHIEF OPERATING OFFICER

    2023-11-16 16:30:00 -0500 2023-11-15 A 36,952 a 36,952 direct

    HIGH SUSANNA GATTI - Officer CHIEF OPERATING OFFICER

    2023-11-16 16:30:00 -0500 2023-11-15 A 94,893 a 189,498 direct -3.3575 0.0 1 -3.3575 2

    FARWELL WILDON - Officer CHIEF MEDICAL OFFICER

    2023-11-16 16:29:48 -0500 2023-11-15 A 32,131 a 32,131 direct

    FARWELL WILDON - Officer CHIEF MEDICAL OFFICER

    2023-11-16 16:29:48 -0500 2023-11-15 A 82,512 a 171,762 direct -3.3575 0.0 1 -3.3575 2

    BRUMM JOSHUA T - Director - Officer SEE REMARKS

    2023-11-16 16:29:18 -0500 2023-11-15 A 139,750 a 139,750 direct

    BRUMM JOSHUA T - Director - Officer SEE REMARKS

    2023-11-16 16:29:18 -0500 2023-11-15 A 358,877 a 592,556 direct -3.3575 0.0 1 -3.3575 2

    MCNEILL JONATHAN - Officer CHIEF BUSINESS OFFICER

    2023-11-16 16:34:50 -0500 2023-11-15 A 37,445 a 37,445 direct

    MCNEILL JONATHAN - Officer CHIEF BUSINESS OFFICER

    2023-11-16 16:34:50 -0500 2023-11-15 A 96,158 a 156,763 direct -3.3575 0.0 1 -3.3575 2

    SCALZO RICHARD WILLIAM - Officer SEE REMARKS

    2023-11-16 16:35:22 -0500 2023-11-15 A 34,946 a 34,946 direct

    SCALZO RICHARD WILLIAM - Officer SEE REMARKS

    2023-11-16 16:35:22 -0500 2023-11-15 A 89,742 a 130,537 direct -3.3575 0.0 1 -3.3575 2

    HIGH SUSANNA GATTI - Officer CHIEF OPERATING OFFICER

    2023-11-02 17:16:26 -0400 2023-11-02 S 9,939 $7.40 d 94,605 direct yes -0.8505 5.7108 13.6087 3 -0.8505 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DYNE THERAPEUTICS INC DYN 2023-11-27 22:15:04 UTC 4.9119 0.4081 750000
    DYNE THERAPEUTICS INC DYN 2023-11-27 21:45:04 UTC 4.9119 0.4081 750000
    DYNE THERAPEUTICS INC DYN 2023-11-27 21:15:03 UTC 4.9119 0.4081 750000
    DYNE THERAPEUTICS INC DYN 2023-11-27 20:45:04 UTC 4.9119 0.4081 750000
    DYNE THERAPEUTICS INC DYN 2023-11-27 20:15:05 UTC 4.9119 0.4081 750000
    DYNE THERAPEUTICS INC DYN 2023-11-27 19:45:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 19:15:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 18:45:05 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 18:15:03 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 17:45:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 17:15:03 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 16:45:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 16:15:03 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 15:45:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 15:15:03 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 14:45:03 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 14:15:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 13:45:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 13:15:04 UTC 4.9119 0.4081 600000
    DYNE THERAPEUTICS INC DYN 2023-11-27 12:45:04 UTC 4.9119 0.4081 600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments